Navigation Links
Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
Date:6/28/2009

S. MAMEDE DO CORONADO, Portugal, June 29 /PRNewswire/ -- Data presented today, in Budapest, demonstrated that add-on treatment with the novel, once-daily anti-epileptic Zebinix(R)* (eslicarbazepine acetate; ESL) resulted in a marked and sustained decrease in seizure frequency over the long-term(1).

Results from the one-year extension of a pivotal Eslicarbazepine Acetate phase III study were presented at the International Congress for Epilepsy in Budapest, Hungary. Patients not controlled with existing anti-epileptic drugs who were given eslicarbazepine acetate as an add-on treatment experienced a mean reduction in seizure frequency of more than 61% (95%CI: -68.2%, -55.5%)1. Nearly 65% of patients were classified as responders, meaning that they had achieved at least a 50% reduction in seizure frequency with Zebinix(R) treatment(1).

"These data continue to demonstrate the efficacy and safety of Zebinix(R) in the treatment of partial onset seizures", said Joyce Cramer, research scientist at Yale University School of Medicine, USA and President of The Epilepsy Therapy Project. "Epilepsy is a devastating condition that can be very difficult to manage and the availability of eslicarbazepine acetate adds an important new choice of therapy for patients who are in vital need of better seizure control."

Epilepsy is one of the most common neurological diseases, affecting approximately one in 100 people6. Treatment of partial-onset seizures, the most common type of epilepsy, remains a constant challenge and up to 40% of patients with partial seizures do not achieve seizure control with current anti-epileptics(2).

Additional studies presented at the IEC further reinforce the efficacy and safety of eslicarbazepine acetate in the treatment of partial-onset seizures, with or without secondary generalisation(3,4).

Pooled data from more than 1,000 patients enrolled in th
'/>"/>

SOURCE BIAL
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
2. Semafores SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients
3. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
4. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
5. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
6. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
9. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
10. Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)
11. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... , Switzerland , February 9 ... global biopharmaceutical group of companies with,a focus ... target unmet medical,needs, today announced the signature ... the development, manufacture and commercialisation of Debio ... with a,potent anti-hepatitis C virus (HCV) effect. ...
(Date:2/8/2010)... PreXion, Inc., ( www.prexion.com ) the ... for dentistry, today announced that it has appointed ... PreXion President/COO Robert Meier commented, "We are ... and I look forward to working with him in ... and success in the dental and high tech medical ...
(Date:2/8/2010)... Feb. 8 Rapid developments ... steady increase in the use and cost of ... arthritis and psoriasis. This has led to some ... costs and medication coverage being spread over both ... new solution with Medication Cost Integration (MCI), which ...
Breaking Medicine Technology:Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 2Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 3PreXion, Inc. Announces Appointment of Director of Marketing 2RegenceRx Leads the Industry With Introduction of Medication Cost Integration 2RegenceRx Leads the Industry With Introduction of Medication Cost Integration 3Doctor Building Nutritarian Army to Fight Disease 65240 1Doctor Building Nutritarian Army to Fight Disease 65240 2Doctor Building Nutritarian Army to Fight Disease 65240 3Hakuna Staff Scheduling Software is Proud To Announce the Launch of Its Online Employee Scheduling Program 65238 1Hakuna Staff Scheduling Software is Proud To Announce the Launch of Its Online Employee Scheduling Program 65238 2Endo and Jubilant Expand Oncology Discovery Partnership on Successful Delivery of Early Milestone 15419 1Endo and Jubilant Expand Oncology Discovery Partnership on Successful Delivery of Early Milestone 15419 2Endo and Jubilant Expand Oncology Discovery Partnership on Successful Delivery of Early Milestone 15419 3
... - Results from phase III,clinical trials and further ... of the European Academy of,Dermatology and Venereology (EADV). ... alitretinoin as a potential once,daily oral treatment for ... no approved treatment exists for severe Chronic Hand,Eczema ...
... MENLO PARK, Calif.--(BUSINESS WIRE)--May,21, 2007 - ChemGenex ... of new clinical data relevant to the ... and the T315I mutation in Philadelphia-positive leukemias",by ... University of,Bologna, Italy (Haematologica Volume 92, pages ...
Other Medicine Technology:Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 2Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 3
(Date:2/9/2010)... EAST LANSING, Mich.- Michigan State University has launched ... designed to address product counterfeiting- which the FBI ... , The counterfeiting of products- from pharmaceuticals to ... of billions of dollars in global trade and ... the economy, the environment and national security. Terrorist ...
(Date:2/9/2010)... fictional television drama may be more effective in persuading ... program on the same issue, according to a new ... a televised drama about a teen pregnancy felt more ... led to more support for using birth control. , ... difficulties caused by teen pregnancies were unmoved, and had ...
(Date:2/9/2010)... MD -- The first results from a large-scale ... African countries reveal that a high percentage of ... quality and thus may contribute to the growth ... the most virulent form of malaria. The findings, ... Medicines (PQM) Program, a USAID-funded program implemented by ...
(Date:2/9/2010)... The following is a statement by PolicyLink ... childhood obesity epidemic will require the kind of clear-eyed ... ,, "As the First Lady stressed, too many ... soda -- and few healthy food options. For many ... extends far beyond the school yard. Millions of poor ...
(Date:2/9/2010)... The Quantum Foundation is proud to be ... Palm Beach County that will help kids and ... Johnson Foundation (RWJF) recently announced a $360,000 grant ... healthy foods for children and families in Lake Worth ... a rigorous selection process that drew more than 500 proposals ...
Breaking Medicine News(10 mins):Health News:MSU launches first anti-counterfeiting research program 2Health News:MSU launches first anti-counterfeiting research program 3Health News:TV drama can be more persuasive than news program, study finds 2Health News:TV drama can be more persuasive than news program, study finds 3Health News:TV drama can be more persuasive than news program, study finds 4Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 2Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 3Health News:Planting Seeds to Fight Childhood Obesity 2
... stages of pregnancy seems to increase the size of the infant, ... fish // may boost the fetal growth rate during pregnancy. They ... was to deliver a low birth weight baby. ,Researchers ... pregnancies. In women who ate no fish, that rate increased to ...
... Recent research show individuals in lower socioeconomic groups, as measured ... with // higher socioeconomic status, but their stress is more ... those with more education have more days of stress, they ... more than 1,000 adults were interviewed daily for eight days, ...
... link between certain types of bedding and frequent wheezing ... an association between frequent wheezing and synthetic quilts and ... were those reported as foam, sponge, tontine, polyester or ... were classified as synthetic. ,The study also shows ...
... to a complex disorder that combines a chronic activation of ... of T-cells, which are involved in immune response. If the ... weakened immune system is less able to fight infections, and ... drug that suppresses the immune system can delay the onset ...
... caffeine throughout the day is found to be a more ... their findings researchers say, most of the population is using caffeine ... tea in the morning, or three cups on the way to ... falling as the day goes on. ,Nearly 20 male participants ...
... Researchers say they now think they have discovered a way ... called the early // prostate cancer antigen, or EPCA can ... development of cancer . ,However specialists, says one ... of prostate cancer is that PSA levels often fluctuate. They ...
Other Medicine News:
... Healing Shoe offers the most advanced design ... allowing patients to maintain their mobility. Thanks ... even larger portion of the forefoot is ... heads and toes to heal faster. OrthoWedge ...
The choice for inclement weather. This boot provides both closed toe and heel with a moisture resistant vinyl upper....
Ideal for use with thinner casting materials such as polyester or fiberglass. Conforms to any casting material....
This lightweight cast boot features a sturdy canvas upper. The three layer EVA rocker outsole provides excellent shock absorption....
Medicine Products: